ArticlePloS one2026
Heat-actuated valve implementation in a point-of-care, paper-based microfluidic device for infectious disease detection.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paper-based microfluid devices have great potential to perform complex assays like nucleic acid amplification tests (NAATs) in point-of-care (POC) and low resource settings, but have not often succeeded because there is frequently need for affordable and simple solutions to address complex fluidics and sample delivery without risk of contamination. These issues are exacerbated when multiple sample processing procedures must be automated by valve integration in the absence of advanced supportive instrumentation or trained personnel. For NAAT application in remote or home environments, valving within a POC device must facilitate precise fluidic movement and physically separate each chemical processing step. Ideally, the valve should also be affordable, easy to manufacture, robust in varying climate environments, reliable when stored under ambient conditions, affordable, and non-reactive with chemical reagents or samples. Here, we report the design and integration of two adaptable thermally-actuated valves for application in a point-of-care, paper-based rapid analysis device. Both valves are designed to facilitate the fluidic movement and control necessary to enable reverse-transcriptase loop-mediated isothermal amplification (RT-LAMP) reactions in a paper-based device. Each valve could be used independently or alongside the other valve to control fluidic movement at specific locations along the paper fluidic pathway. The valves differ in their material composition, fabrication, and mechanisms for fluidic control, but both are affordable, durable, and simple to use. We demonstrated that each valve could be used to enable RT-LAMP reactions in a paper-based device for detecting either RNA or DNA biomarkers for respiratory infectious diseases (COVID and Flu A) from human nasal swabs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.